Danielle B. Halpern

Internal Medicine

75 Francis St
Boston, MA 02115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

An open-label study evaluating the safety and efficacy of AMO-01 for the treatment of seizures in Phelan-McDermid syndrome.

An open-label study evaluating the safety and efficacy of AMO-01 for the treatment of seizures in Phelan-McDermid syndrome.

Journal: HGG advances

Published: March 29, 2024

Genetic Subtypes of Phelan-McDermid Syndrome Exhibit Similar Rates of Change Despite Differences in Level of Impairment in Developmental Constructs.

Genetic Subtypes of Phelan-McDermid Syndrome Exhibit Similar Rates of Change Despite Differences in Level of Impairment in Developmental Constructs.

Journal: American journal on intellectual and developmental disabilities

Published: March 13, 2024

Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome.

Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome.

Journal: Journal of neurodevelopmental disorders

Published: March 04, 2024

Prospective phenotyping of CHAMP1 disorder indicates that coding mutations may not act through haploinsufficiency.

Prospective phenotyping of CHAMP1 disorder indicates that coding mutations may not act through haploinsufficiency.

Journal: Human genetics

Published: April 11, 2023

DDX3X Syndrome: Summary of Findings and Recommendations for Evaluation and Care.

DDX3X Syndrome: Summary of Findings and Recommendations for Evaluation and Care.

Journal: Pediatric neurology

Published: April 14, 2022

An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome.

An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome.

Journal: HGG advances

Published: December 28, 2021

CHAMP1 disorder is associated with a complex neurobehavioral phenotype including autism, ADHD, repetitive behaviors and sensory symptoms.

CHAMP1 disorder is associated with a complex neurobehavioral phenotype including autism, ADHD, repetitive behaviors and sensory symptoms.

Journal: Human molecular genetics

Published: November 19, 2021

Neural Markers of Auditory Response and Habituation in Phelan-McDermid Syndrome.

Neural Markers of Auditory Response and Habituation in Phelan-McDermid Syndrome.

Journal: Frontiers in neuroscience

Published: November 16, 2021

Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder.

Neurocognitive Outcomes from Memantine: A Pilot, Double-Blind, Placebo-Controlled Trial in Children with Autism Spectrum Disorder.

Journal: Journal of child and adolescent psychopharmacology

Published: September 20, 2021

Investigating social orienting in children with Phelan-McDermid syndrome and 'idiopathic' autism.

Investigating social orienting in children with Phelan-McDermid syndrome and 'idiopathic' autism.

Journal: Journal of neurodevelopmental disorders

Published: July 30, 2021

Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium.

Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium.

Journal: Human molecular genetics

Published: July 28, 2021

Individuals with FOXP1 syndrome present with a complex neurobehavioral profile with high rates of ADHD, anxiety, repetitive behaviors, and sensory symptoms.

Individuals with FOXP1 syndrome present with a complex neurobehavioral profile with high rates of ADHD, anxiety, repetitive behaviors, and sensory symptoms.

Journal: Molecular autism

Published: May 10, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026